Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4685876

N=C(N)Nc1ccc(C(=O)O)s1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DAO P14920 6/20 0.45
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
KLK1 P06870 2/20 0.35
KLK5 Q9Y337 2/20 0.35
RNASEH1 O60930 1/20 0.35
PKM P14618 2/20 0.34
GAA P10253 2/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LIG1 P18858 1/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
KDM4E B2RXH2 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4684147 0.89 DAO (0.42) DAOALDH1A1RNASEH1PKMGAA
Trifluoroacetic Acid SCHEMBL4682272 0.81 HDAC4 (0.56) ALDH1A1HPGDHSD17B10HDAC1HDAC6
SCHEMBL4685880 0.78 HDAC4 (0.35) HPGDRNASEH1PKMGAAALOX15
SCHEMBL5161529 0.72 RNASEH1 (0.50) KLK1RNASEH1F2
Phenylguanidine SCHEMBL7425328 0.71 CHIT1 (0.49) ALDH1A1KLK1KLK5GAAHSD17B10
SCHEMBL6735515 0.71 PKM (0.69) DAOHPGDRNASEH1PKMGAA
SCHEMBL1483584 0.70 IDO1 (0.42) DAOALDH1A1RNASEH1PKMGAA
SCHEMBL12368674 0.68 DAO (0.47) DAOHPGDRNASEH1PKMGAA
Trifluoroacetic Acid SCHEMBL30725604 0.68 KLK1 (0.51) ALDH1A1KLK1KLK5KDM4EF2
SCHEMBL28482288 0.67 RNASEH1 (0.68) ALDH1A1HPGDRNASEH1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236712-B1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE AJINOMOTO KK (JP) 2008-08-06 EP disclosed
US-6710056-B2 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVE AN EXCELLENT ANTAGONISTIC EFFECT AGAINST ACTIVATED BLOOD COAGULATION FACTOR VII. AJINOMOTO CO., INC. (JP) 2004-03-23 US disclosed
US-20030109547-A1 Amidinophenylpyruvic acid derivatives AJINOMOTO CO. INC (JP) 2003-06-12 US disclosed
EP-1236712-A1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE Ajinomoto Co., Inc. (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109547-A1 Amidinophenylpyruvic acid derivatives HABP2, F2, F7 DAO 878/4885ALDH1A1 622/4885HPGD 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.